Neumarz Market Outlook January 2026
2026 M&A trends: why European and Swiss buyers are targeting US assets, plus outlook on healthcare, financial services, and energy consolidation.
Read More
The 2026 Strategic Horizon: Capital Allocation in an Era of Physical Scarcity and Fiscal Dominance
As the 2023-2025 cycle concludes, market consensus suggests a fundamental regime change. The "high nominal growth" era is giving way to a period defined by shrinking cash yields, physical resource constraints, and aggressive industrial policy.
Read More
Neumarz Market Intelligence Brief – November 2025
November 2025 encapsulates that transition. Markets reward foresight, governance and technical mastery. Corporations operating between Switzerland, Western Europe and the United States stand at the frontier of that transformation. Liquidity endures, but leadership belongs to those who know how to use it.
Read More
Europe’s Big AI Bet: How New Guidelines Will Shape the Future of General-Purpose AI Models
Europe’s Bold Step into AI’s Future Setting Clear Boundaries for AI Innovation...
Read More
WCAG vs EAA: Understanding Where WCAG Stops and the EAA Starts
Digital accessibility is increasingly critical for modern organisations. Teams generally understand the importance of meeting Web Content Accessibility Guidelines (WCAG). Yet, to genuinely grasp digital accessibility today, organisations must look beyond WCAG and embrace the broader, more comprehensive requirements of the European Accessibility Act (EAA), guided by EN 301 549 and EN 17161¹.
Read More
Why Non-Financial Benefits Are Becoming the Real Currency of Work
The Conversation That Changed the Tone Emma, 28, walked into her manager’s...
Read More
Ipsen's Strategic Transformation: A Comprehensive Case Study
David Loew took over as CEO of Ipsen during a turbulent period marked by a 70% drop in share price due to the FDA’s hold on palovarotene, a drug for a rare bone disease. Concurrently, their flagship product, Somatuline, faced new generic competition, and the company’s R&D pipeline was heavily skewed towards late-stage assets, posing significant challenges.
Read More